Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Transglutaminase/protease, putative | 0.0544 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0544 | 0.5 | 0.5 |
Echinococcus granulosus | Transglutaminase | 0.0544 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0544 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0544 | 0.5 | 0.5 | |
Mycobacterium tuberculosis | Conserved protein | 0.0544 | 0.5 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0544 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0544 | 0.5 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0544 | 0.5 | 0.5 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0544 | 0.5 | 0.5 |
Trichomonas vaginalis | peptide N-glycanase, putative | 0.0544 | 0.5 | 0.5 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0544 | 0.5 | 0.5 |
Mycobacterium ulcerans | putative transglutaminase-like protein | 0.0544 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Long conserved protein | 0.0544 | 0.5 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0544 | 0.5 | 0.5 |
Echinococcus multilocularis | Transglutaminase | 0.0544 | 0.5 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0544 | 0.5 | 0.5 |
Mycobacterium ulcerans | transglutaminase family protein | 0.0544 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IZ (functional) | = 13 mm | Antibacterial activity against Escherichia coli at 50 ug/ml after 24 hr by agar diffusion method | ChEMBL. | No reference |
MIC (functional) | = 44.5 ug ml-1 | Antibacterial activity against Escherichia coli after 24 hr | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.